Concerning breast cancer, knockdown of SRGN in mesenchymal-like MDA-MB-231 and the induction of the SRGN expression in epithelial MCF-7 cancer cells confirmed the vital role of SRGN in the induction of EMT [154,155]. Here, SRGN is linked to breast cancer.